相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Capecitabine/cisplatin versus 5-fluorouracil/cisplatin as first-line therapy in patients with advanced gastric cancer: a randomised phase III noninferiority trial
Y. -K. Kang et al.
ANNALS OF ONCOLOGY (2009)
Fluorouracil versus combination of irinotecan plus cisplatin versus S-1 in metastatic gastric cancer: a randomised phase 3 study
Narikazu Boku et al.
LANCET ONCOLOGY (2009)
Phase III trial in metastatic gastroesophageal adenocarcinoma with fluorouracil, leucovorin plus either oxaliplatin or cisplatin:: A study of the arbeitsgemeinschaft internistische onkologie
Salah-Eddin Al-Batran et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Capecitabine and oxaliplatin for advanced esophagogastric cancer
David Cunningham et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Phase II Study of Weekly Paclitaxel by One-Hour Infusion for Advanced Gastric Cancer
Yasunori Emi et al.
SURGERY TODAY (2008)
A phase II study of oxaliplatin with low-dose leucovorin and bolus and continuous infusion 5-fluorouracil (modified FOLFOX-4) for gastric cancer patients with malignant ascites
Sung Yong Oh et al.
JAPANESE JOURNAL OF CLINICAL ONCOLOGY (2007)
Prognostic model to predict survival following first-line chemotherapy in patients with metastatic gastric adenocarcinoma
J. Lee et al.
ANNALS OF ONCOLOGY (2007)
Phase III study of docetaxel and cisplatin plus fluorouracil compared with cisplatin and fluorouracil as first-line therapy for advanced gastric cancer: A report of the V325 study group
Eric Van Cutsem et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
Pharmacokinetic study of paclitaxel in malignant ascites from advanced gastric cancer patients
Michiya Kobayashi et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2006)
Global cancer statistics, 2002
DM Parkin et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2005)
Patterns of initial recurrence in completely resected gastric adenocarcinoma
M D'Angelica et al.
ANNALS OF SURGERY (2004)
Score based on hypoalbuminemia and elevated C-reactive protein predicts survival in patients with advanced gastrointestinal cancer
MM Elahi et al.
NUTRITION AND CANCER-AN INTERNATIONAL JOURNAL (2004)
Phase II trial of paclitaxel by three-hour infusion for advanced gastric cancer with short premedication for prophylaxis against paclitaxel-associated hypersensitivity reactions
Y Yamada et al.
ANNALS OF ONCOLOGY (2001)
Recurrence following curative resection for gastric carcinoma
CH Yoo et al.
BRITISH JOURNAL OF SURGERY (2000)
分享论文
